Paper4156792
Dose equivalence of the antipsychotic drugs.
Davis JM. J Psychiatr Res, 1974. Cited by 300 papers, by iCite.
Cite this record
ConductScience Library. Dose equivalence of the antipsychotic drugs. Papers, record 4156792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4156792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Chlorprothixene | Major topic |
| Haloperidol | Major topic |
| Therapeutic Equivalency | Major topic |
| Administration, Oral | |
| Biological Availability | |
| Chlorpromazine | |
| Clinical Trials as Topic | |
| Humans | |
| Injections, Intramuscular | |
| Injections, Intravenous |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 300 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41420713 | Antipsychotic load during olanzapine mono- versus polytherapy and in relation to age. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/41420713 | PubMed |
| 40914753 | GABAA receptor availability in clinical high-risk and first-episode psychosis: a [11C]Ro15-4513 positron emission tomography study. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/40914753 | PubMed |
| 40329432 | Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/40329432 | PubMed |
| 39073446 | Deficit of satellite oligodendrocytes of neurons in the rostral part of the head of the caudate nucleus in schizophrenia. | Eur Arch Psychiatry Clin Neurosci | 2025 | https://conductscience.org/library/papers/39073446 | PubMed |
| 38672143 | Clinical and Sociodemographic Correlations with Neurological Soft Signs in Hospitalized Patients with Schizophrenia: A Preliminary Longitudinal Study. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672143 | PubMed |
| 38582925 | The Ethiopian Cognitive Assessment battery in Schizophrenia (ECAS): a validation study. | Schizophrenia (Heidelb) | 2024 | https://conductscience.org/library/papers/38582925 | PubMed |
| 38159078 | Development and Evaluation of a Cognitive Battery for People With Schizophrenia in Ethiopia. | Schizophr Bull | 2024 | https://conductscience.org/library/papers/38159078 | PubMed |
| 36789916 | Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia. | BMJ Ment Health | 2023 | https://conductscience.org/library/papers/36789916 | PubMed |
| 36428507 | The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia. | Biomedicines | 2022 | https://conductscience.org/library/papers/36428507 | PubMed |
| 35078949 | Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder. | Clin Psychopharmacol Neurosci | 2022 | https://conductscience.org/library/papers/35078949 | PubMed |
| 34822006 | Reduced number of satellite oligodendrocytes of pyramidal neurons in layer 5 of the prefrontal cortex in schizophrenia. | Eur Arch Psychiatry Clin Neurosci | 2022 | https://conductscience.org/library/papers/34822006 | PubMed |
| 34406325 | Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis. | JAMA Psychiatry | 2021 | https://conductscience.org/library/papers/34406325 | PubMed |
| 33098300 | Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis. | Schizophr Bull | 2021 | https://conductscience.org/library/papers/33098300 | PubMed |
| 32848955 | Categorical and Dimensional Approaches to Examining the Joint Effect of Autism and Schizotypal Personality Disorder on Sustained Attention. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/32848955 | PubMed |
| 32840872 | Maintenance treatment with antipsychotic drugs for schizophrenia. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32840872 | PubMed |
| 32349756 | Association between sleep quality and domains of quality of life amongst patients with first episode psychosis. | Health Qual Life Outcomes | 2020 | https://conductscience.org/library/papers/32349756 | PubMed |
| 32154121 | Evaluation of social cognitive measures in an Asian schizophrenia sample. | Schizophr Res Cogn | 2020 | https://conductscience.org/library/papers/32154121 | PubMed |
| 31704157 | Reduced in vivo visual cortex GABA in schizophrenia, a replication in a recent onset sample. | Schizophr Res | 2020 | https://conductscience.org/library/papers/31704157 | PubMed |
| 31178367 | Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. | Lancet Psychiatry | 2019 | https://conductscience.org/library/papers/31178367 | PubMed |
| 30618882 | Determinants of Health-Related Quality of Life in Schizophrenia: Beyond the Medical Model. | Front Psychiatry | 2018 | https://conductscience.org/library/papers/30618882 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4156792
GET https://conductscience.org/api/papers/v1/4156792/cited_by?page=2